01 1Mylan Laboratories Limited
02 1Tianish Laboratories Private Limited
01 2Olsalazine Sodium
01 1India
02 1U.S.A
NDC Package Code : 84206-0071
Start Marketing Date : 2024-10-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-901
Start Marketing Date : 2024-03-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Olsalazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olsalazine, including repackagers and relabelers. The FDA regulates Olsalazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olsalazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olsalazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olsalazine supplier is an individual or a company that provides Olsalazine active pharmaceutical ingredient (API) or Olsalazine finished formulations upon request. The Olsalazine suppliers may include Olsalazine API manufacturers, exporters, distributors and traders.
click here to find a list of Olsalazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Olsalazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Olsalazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Olsalazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Olsalazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Olsalazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Olsalazine suppliers with NDC on PharmaCompass.
We have 2 companies offering Olsalazine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
